Oncology & Cancer

Corticorelin acetate has steroid-sparing effect in brain cancer

(HealthDay)—Corticorelin acetate (CrA) administration to patients with peritumoral brain edema (PBE) allows the reduction of steroid doses and is associated with reduced incidence and severity of steroid-induced myopathy ...

Oncology & Cancer

New research may aid treatment of multiple myeloma patients

A study led by Robert G. Hawley, Ph.D., professor and chair of the department of anatomy and regenerative biology at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), may help predict which ...

Oncology & Cancer

New hematuria risk index IDs patients at low cancer risk

(HealthDay)—A Hematuria Risk Index could identify cancer risk among patients with asymptomatic microscopic hematuria, according to a study published online Jan. 11 in the Mayo Clinic Proceedings.

Oncology & Cancer

Cocktail boosts immune cells in fighting cancer

Natural killer cells, as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer ...

Oncology & Cancer

Researcher pieces together AML prognosis puzzle

When patients suffering from Acute Myeloid Leukemia (AML) express high levels of the gene, MN1, an already aggressive leukemia is accelerated and shortens survival time. While that's a known fact, the mechanisms involved ...

page 9 from 12